Optinose investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates adequacy of price and process in proposed sale of optinose, inc. - optn

New york & new orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed sale of optinose, inc. (nasdaqgs: optn) to paratek pharmaceuticals. under the terms of the proposed transaction, shareholders of optinose will receive $9.00 per share in cash, plus up to $5.00 per share in contingent value rights payable in the event that certain net revenue milestones are achieved by xhanc.
GM Ratings Summary
GM Quant Ranking